Navidea Biopharma (NAVB) Reports Publication of Study Examining Use of Tc99m Tilmanocept for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Melanoma and Oral Cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
(2022-05-24 | NYSEAM:NAVB) Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting
Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the Tumor Myeloid-Directed Therapies Summit Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Navidea Biopharmaceuticals Announces the Regulatory Approval of Lymphoaim in India - read this article along with other careers information, tips and advice on BioSpace
Navidea Biopharmaceuticals Reports Fourth Quarter 2021 Financial Results - read this article along with other careers information, tips and advice on BioSpace